Squarepoint Ops LLC Boosts Holdings in Henry Schein, Inc. $HSIC

Squarepoint Ops LLC grew its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 724.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,841 shares of the company’s stock after purchasing an additional 41,159 shares during the period. Squarepoint Ops LLC’s holdings in Henry Schein were worth $3,422,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in HSIC. Ameriprise Financial Inc. boosted its stake in Henry Schein by 3,275.2% during the second quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company’s stock valued at $165,594,000 after buying an additional 2,199,695 shares during the period. Norges Bank purchased a new stake in shares of Henry Schein in the 2nd quarter valued at about $89,476,000. M.D. Sass LLC bought a new stake in shares of Henry Schein during the 2nd quarter valued at about $79,201,000. Schroder Investment Management Group grew its holdings in shares of Henry Schein by 149.3% during the second quarter. Schroder Investment Management Group now owns 1,563,899 shares of the company’s stock worth $114,243,000 after purchasing an additional 936,471 shares in the last quarter. Finally, Bank of America Corp DE increased its position in shares of Henry Schein by 204.2% in the second quarter. Bank of America Corp DE now owns 995,375 shares of the company’s stock worth $72,712,000 after purchasing an additional 668,182 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $77.05 on Wednesday. The company’s fifty day moving average is $69.66 and its 200 day moving average is $69.61. The company has a quick ratio of 0.79, a current ratio of 1.40 and a debt-to-equity ratio of 0.54. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The stock has a market cap of $9.07 billion, a PE ratio of 24.38, a PEG ratio of 2.37 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a return on equity of 14.76% and a net margin of 3.02%.The firm had revenue of $3.34 billion for the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. Research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on HSIC shares. Barclays assumed coverage on shares of Henry Schein in a research report on Monday, December 8th. They set an “overweight” rating and a $86.00 target price for the company. Morgan Stanley upped their target price on shares of Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a research report on Wednesday, November 5th. Barrington Research set a $79.00 price target on Henry Schein and gave the company an “outperform” rating in a research report on Wednesday, November 5th. Wall Street Zen raised Henry Schein from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Wells Fargo & Company upped their price objective on Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 5th. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $76.92.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.